ubiquitin specific peptidase 32 pseudogene 1Genealiases: []
Q-omics provides the consensus-scored USP32P1 profile across patient tissues and cancer cell-line models. USP32P1 expression is associated with patient survival in 19 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, USP32P1 is differentially expressed in 4, with the highest sampling consensus in KICH. Additionally, USP32P1 RNA expression shows 14,076 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight UVM, KICH, and TGCT as cancer lineages where USP32P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for USP32P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes USP32P1 survival associations across molecular data types. USP32P1 RNA expression shows survival associations in the most cancer types (19). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible USP32P1 RNA expression–survival associations across cancer types. High USP32P1 expression shows unfavorable associations in UVM, MESO and CESC, but favorable associations in SKCM, BLCA and KIRC. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for USP32P1 RNA expression.
This table summarizes USP32P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in BRCA for RNA.
This table ranks reproducible tumor–normal expression differences for USP32P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. USP32P1 shows lower tumor expression in BRCA and COAD and higher tumor expression in KICH and KIRC. The KICH box plot shows higher USP32P1 RNA expression in tumor versus normal tissue (log2 FC = +0.270, t-test p = .022).
This table shows molecular features associated with USP32P1 in patient tissues and cancer cell lines. In patient samples, USP32P1 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
